Document is current
Any future updates will be listed below
-
Authors
Diao, Xiaotong https://orcid.org/0000-0001-8449-6688
Shang, Qinghong
Guo, Mengqi
Huang, Yubin
Zhang, Meina
Chen, Xiaoyu
Liang, Yinping
Sun, Xiangnan
Zhou, Fan
Zhuang, Jingjing
Liu, Shuang-Jiang https://orcid.org/0000-0002-7585-310X
Vogel, Christoph F. A.
Rastinejad, Fraydoon https://orcid.org/0000-0002-0784-9352
Wu, Dalei https://orcid.org/0000-0003-1817-7229
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82373876, 22177063)
National Key R&D Program of China
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 23 January 2025
First Online: 3 February 2025
Competing interests
: F.R. is a founder and consultant for Flare Therapeutics. The remaining authors declare no competing interests.
